ELRAGLUSIB + Gemcitabine Hydrochloride

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

ELRAGLUSIB + Gemcitabine Hydrochloride
Treatment and conditionWhere it standsTrials
ELRAGLUSIB + Gemcitabine Hydrochloride for gliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ELRAGLUSIB + Gemcitabine Hydrochloride for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ELRAGLUSIB + Gemcitabine Hydrochloride for neoplasm metastasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ELRAGLUSIB + Gemcitabine Hydrochloride for sarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1